Company Filing History:
1 out of 798 
1 out of 1 
1 out of 832,912 Years Active: 2001-2006
Title: An Insight into the Innovative Mind of James R. Damon
Introduction
James R. Damon, hailing from Chalfont, PA, has made significant contributions to the field of pharmaceuticals with his inventive spirit. With a total of three patents to his name, Damon is recognized for his innovative approaches to medication formulation, particularly in the creation of chewable tablets.
Latest Patents
Among his most notable inventions are two recent patents focused on soft chewable tablets. The first patent describes a compressed, chewable tablet formulated with at least one active ingredient, a water-disintegratable and compressible carbohydrate, as well as a binder. These ingredients are meticulously dry blended and compressed into a convex-shaped tablet designed for optimal hardness ranging from about 2 to about 11 kp/cm, boasting a remarkable friability of less than 1%. The second patent mirrors this formulation, emphasizing the unique convex-shaped design that enhances user experience and efficacy in delivery.
Career Highlights
Throughout his career, James has worked with prominent companies including McNeil-PPC, Inc., where he further honed his expertise in pharmaceutical products. His time at McNeil-PPC contributed significantly to his understanding of product development and innovation in the pharmaceutical industry.
Collaborations
Collaboration has played a key role in Damon's journey. He has worked closely with talented individuals like Ronni L. Robinson and James R. Mossop. These partnerships have aided in the advancement of his inventions and have enriched the innovative environment surrounding his work.
Conclusion
James R. Damon stands out as a remarkable inventor in the realm of pharmaceutical innovations. His latest patents on soft chewable tablets illustrate not only his creativity but also his dedication to improving medication delivery. With a solid foundation in the industry and valuable collaborations, Damon's contributions are sure to have a lasting impact on pharmaceutical innovation.